| Name | BriaCell Therapeutics Corp. |
|---|---|
| CIK | 0001610820 |
| Tickers | BCTX, BCTXL, BCTXZ |
| Exchanges | Nasdaq, Nasdaq, Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 0731 |
| State of incorporation | A1 British Columbia, Canada |
| Phone | (604) 921-1810 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
324 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-10-28 | 10-K | 10-K | 0001493152-26-049041 | 001-40101 | 261496395 | 34 | 13479960 | 1 | 1 | |
| 2026-06-26 | 8-K | 8-K | 7.01,9.01 | 0001493152-26-030286 | 001-40101 | 261129027 | 34 | 1689214 | 1 | 1 |
| 2026-06-09 | 10-Q | 10-Q | 0001493152-26-027928 | 001-40101 | 261076098 | 34 | 7084822 | 1 | 1 | |
| 2026-06-03 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001493152-26-026953 | 001-40101 | 261058694 | 34 | 1012897 | 1 | 1 |
| 2026-06-02 | 424B5 | 424B5 | 0001493152-26-026759 | 333-276650 | 261053658 | 33 | 882653 | |||
| 2026-03-31 | 8-K | 8-K | 7.01,9.01 | 0001493152-26-014156 | 001-40101 | 26821820 | 34 | 1999677 | 1 | 1 |
| 2026-03-10 | 10-Q | 10-Q | 0001493152-26-009557 | 001-40101 | 26740380 | 34 | 7230854 | 1 | 1 | |
| 2026-03-09 | 8-K | 8-K | 5.07 | 0001493152-26-009382 | 001-40101 | 26735861 | 34 | 269435 | 1 | 1 |
| 2026-02-26 | 25-NSE | xslF25X02/primary_doc.xml | 0001354457-26-000220 | 001-40101 | 26685961 | 34 | 3151 | |||
| 2026-02-20 | 8-K | 8-K | 8.01,9.01 | 0001493152-26-007587 | 001-40101 | 26659690 | 34 | 294439 | 1 | 1 |
| 2026-02-12 | DEF 14A | DEF 14A | 0001493152-26-006390 | 001-40101 | 26626016 | 34 | 6735099 | 1 | 1 | |
| 2026-01-23 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-006332 | 005-92289 | 26558119 | 34 | 27844 | |||
| 2026-01-15 | 8-K | 8-K | 1.01,8.01,9.01 | 0001493152-26-002430 | 001-40101 | 26536447 | 34 | 1616247 | 1 | 1 |
| 2026-01-14 | 424B4 | 424B4 | 0001493152-26-002258 | 333-292388 | 26533472 | 33 | 402481 | |||
| 2026-01-13 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000157 | 333-292388 | 26531384 | 33 | 1872 | ||
| 2026-01-13 | S-1MEF | S-1MEF | 0001493152-26-002103 | 333-292716 | 26531299 | 33 | 362862 | 1 | 1 | |
| 2026-01-13 | CERT | BCTXL_8-A_Cert_1610820.pdf | 0001354457-26-000037 | 001-40101 | 26530797 | 34 | 120642 | |||
| 2026-01-13 | 8-A12B | 8-A12B | 0001493152-26-001969 | 001-40101 | 26529103 | 34 | 401688 | |||
| 2026-01-08 | CORRESP | filename1.htm | 0001493152-26-000962 | 12879 | ||||||
| 2026-01-08 | CORRESP | filename1.htm | 0001493152-26-000961 | 11327 | ||||||
| 2026-01-06 | CORRESP | filename1.htm | 0001493152-26-000535 | 11543 | ||||||
| 2026-01-06 | CORRESP | filename1.htm | 0001493152-26-000533 | 10448 | ||||||
| 2025-12-29 | 8-K | 8-K | 7.01,9.01 | 0001493152-25-029363 | 001-40101 | 251609170 | 34 | 1146391 | 1 | 1 |
| 2025-12-23 | FWP | FWP | 0001493152-25-028923 | 333-292388 | 251595358 | 34 | 48304291 | |||
| 2025-12-23 | S-1 | S-1 | 0001493152-25-028916 | 333-292388 | 251594896 | 33 | 2243238 | 1 | 1 | |
| 2025-12-11 | 10-Q | 10-Q | 0001493152-25-027240 | 001-40101 | 251565017 | 34 | 5903390 | 1 | 1 | |
| 2025-12-01 | 8-K | 8-K | 7.01,9.01 | 0001493152-25-025469 | 001-40101 | 251536930 | 34 | 1506229 | 1 | 1 |
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000191 | 005-92289 | 251463337 | 34 | 11810 | |||
| 2025-10-16 | DRSLTR | filename1.htm | 0001493152-25-018318 | 10050 | ||||||
| 2025-10-16 | DRS | filename1.htm | 0001493152-25-018316 | 377-08574 | 251397854 | 33 | 589357 | |||
| 2025-10-16 | 10-K | 10-K | 0001493152-25-018212 | 001-40101 | 251396232 | 34 | 12587217 | 1 | 1 | |
| 2025-10-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0002090655-25-000002 | 005-92289 | 251387066 | 34 | 9348 | |||
| 2025-08-26 | 8-K | 8-K | 8.01,9.01 | 0001641172-25-025438 | 001-40101 | 251252409 | 34 | 276147 | 1 | 1 |
| 2025-08-01 | S-8 | S-8 | 0001641172-25-021790 | 333-289157 | 251173251 | 33 | 306805 | 1 | 1 | |
| 2025-07-28 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000930413-25-002258 | 005-92289 | 251154318 | 34 | 18215 | |||
| 2025-07-22 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000130 | 005-92289 | 251138938 | 34 | 15378 | |||
| 2025-07-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000125 | 005-92289 | 251136219 | 34 | 11854 | |||
| 2025-07-16 | 8-K | 8-K | 1.01,8.01,9.01 | 0001641172-25-019892 | 001-40101 | 251127632 | 34 | 1082677 | 1 | 1 |
| 2025-07-16 | 424B4 | 424B4 | 0001641172-25-019807 | 333-288562 | 251126074 | 33 | 996791 | |||
| 2025-07-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002260 | 333-288562 | 251126103 | 33 | 1873 | ||
| 2025-07-15 | CORRESP | filename1.htm | 0001641172-25-019660 | 11279 | ||||||
| 2025-07-15 | CORRESP | filename1.htm | 0001641172-25-019658 | 12483 | ||||||
| 2025-07-14 | CORRESP | filename1.htm | 0001641172-25-019540 | 12485 | ||||||
| 2025-07-14 | CORRESP | filename1.htm | 0001641172-25-019539 | 11281 | ||||||
| 2025-07-11 | CORRESP | filename1.htm | 0001641172-25-018739 | 12108 | ||||||
| 2025-07-11 | CORRESP | filename1.htm | 0001641172-25-018738 | 11440 | ||||||
| 2025-07-11 | FWP | FWP | 0001641172-25-018644 | 333-288562 | 251117207 | 34 | 18023703 | |||
| 2025-07-10 | S-1/A | S-1/A | 0001641172-25-018633 | 333-288562 | 251117099 | 33 | 2267609 | 1 | 1 | |
| 2025-07-09 | S-1/A | S-1/A | 0001641172-25-018347 | 333-288562 | 251112920 | 33 | 1173575 | |||
| 2025-07-08 | FWP | FWP | 0001641172-25-018224 | 333-288562 | 251111481 | 34 | 18887827 | |||
| 2025-07-08 | CORRESP | filename1.htm | 0001641172-25-018221 | 11871 | ||||||
| 2025-07-08 | CORRESP | filename1.htm | 0001641172-25-018220 | 9935 | ||||||
| 2025-07-08 | S-1 | S-1 | 0001641172-25-018193 | 333-288562 | 251111140 | 33 | 2517921 | 1 | 1 | |
| 2025-06-24 | UPLOAD | filename1.pdf | 0000000000-25-006592 | 377-08120 | 40476 | |||||
| 2025-06-18 | DRSLTR | filename1.htm | 0001641172-25-015610 | 10803 | ||||||
| 2025-06-18 | DRS | filename1.htm | 0001641172-25-015605 | 377-08120 | 251057616 | 33 | 1140458 | |||
| 2025-06-18 | 8-K | 8-K | 7.01,9.01 | 0001641172-25-015516 | 001-40101 | 251055223 | 34 | 1181763 | 1 | 1 |
| 2025-06-16 | 10-Q | 10-Q | 0001641172-25-015265 | 001-40101 | 251050674 | 34 | 7889599 | 1 | 1 | |
| 2025-05-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001753926-25-000802 | 005-92289 | 25942290 | 34 | 15617 | |||
| 2025-05-01 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001649553-25-000062 | 005-92289 | 25900120 | 34 | 15250 | |||
| 2025-04-28 | 8-K | form8-k.htm | 1.01,8.01,9.01 | 0001641172-25-006428 | 001-40101 | 25880544 | 34 | 1600569 | 1 | 1 |
| 2025-04-28 | 424B4 | form424b4.htm | 0001641172-25-006361 | 333-286735 | 25876349 | 33 | 919265 | |||
| 2025-04-28 | 424B4 | form424b4.htm | 0001641172-25-006359 | 333-286670 | 25876342 | 33 | 919265 | |||
| 2025-04-24 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001243 | 333-286670 | 25869720 | 33 | 1872 | ||
| 2025-04-24 | S-1MEF | forms-1mef.htm | 0001641172-25-006036 | 333-286735 | 25868867 | 33 | 147305 | |||
| 2025-04-24 | CERT | BCTXZ_8-A_Cert.pdf | 0001354457-25-000352 | 001-40101 | 25868224 | 34 | 128772 | |||
| 2025-04-24 | 8-A12B | form8a12b.htm | 0001641172-25-005992 | 001-40101 | 25867048 | 34 | 341159 | |||
| 2025-04-23 | S-1/A | forms-1a.htm | 0001641172-25-005871 | 333-286670 | 25862239 | 33 | 1393692 | |||
| 2025-04-22 | FWP | formfwp.htm | 0001641172-25-005700 | 333-286670 | 25858039 | 34 | 11401876 | |||
| 2025-04-22 | CORRESP | filename1.htm | 0001641172-25-005685 | 14037 | ||||||
| 2025-04-22 | CORRESP | filename1.htm | 0001641172-25-005681 | 9985 | ||||||
| 2025-04-22 | CORRESP | filename1.htm | 0001641172-25-005678 | 17012 | ||||||
| 2025-04-22 | S-1 | forms-1.htm | 0001641172-25-005677 | 333-286670 | 25857666 | 33 | 2277782 | |||
| 2025-03-24 | UPLOAD | filename1.pdf | 0000000000-25-003111 | 377-07783 | 44771 | |||||
| 2025-03-12 | DRSLTR | filename1.htm | 0001493152-25-010079 | 9191 | ||||||
| 2025-03-12 | DRS | filename1.htm | 0001493152-25-010077 | 377-07783 | 25732573 | 33 | 3043995 | |||
| 2025-03-12 | 10-Q | form10-q.htm | 0001493152-25-010052 | 001-40101 | 25732044 | 34 | 6295747 | 1 | 1 | |
| 2025-03-12 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-25-010035 | 001-40101 | 25731633 | 34 | 1142574 | 1 | 1 |
| 2025-02-13 | 8-K | form8-k.htm | 8.01 | 0001493152-25-006419 | 001-40101 | 25619979 | 34 | 259952 | 1 | 1 |
| 2025-02-10 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001753926-25-000202 | 005-92289 | 25607397 | 34 | 24392 | |||
| 2025-02-06 | 8-K | form8-k.htm | 5.07 | 0001493152-25-005204 | 001-40101 | 25597817 | 34 | 290284 | 1 | 1 |
| 2025-02-05 | 8-K | form8-k.htm | 1.01,3.02,8.01,9.01 | 0001493152-25-005043 | 001-40101 | 25594217 | 34 | 1251169 | 1 | 1 |
| 2025-02-04 | 424B5 | form424b5.htm | 0001493152-25-004856 | 333-276650 | 25588129 | 33 | 1055561 | |||
| 2025-02-03 | 424B5 | form424b5.htm | 0001493152-25-004684 | 333-276650 | 25583107 | 33 | 1052842 | |||
| 2025-01-28 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-003977 | 001-40101 | 25564043 | 34 | 305876 | 1 | 1 |
| 2025-01-03 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-000282 | 001-40101 | 25507501 | 34 | 310866 | 1 | 1 |
| 2025-01-03 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-25-000281 | 001-40101 | 25507500 | 34 | 300900 | 1 | 1 |
| 2025-01-03 | DEFA14A | formdefa14a.htm | 0001493152-25-000283 | 001-40101 | 25507496 | 34 | 848918 | |||
| 2024-12-17 | DEF 14A | formdef14a.htm | 0001493152-24-050399 | 001-40101 | 241555654 | 34 | 2145747 | |||
| 2024-12-16 | 10-Q | form10-q.htm | 0001493152-24-050214 | 001-40101 | 241551821 | 34 | 6004239 | 1 | 1 | |
| 2024-12-16 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-24-050212 | 001-40101 | 241551815 | 34 | 1024623 | 1 | 1 |
| 2024-12-13 | 8-K | form8-k.htm | 1.01,3.02,8.01,9.01 | 0001493152-24-049999 | 001-40101 | 241548558 | 34 | 1648718 | 1 | 1 |
| 2024-12-12 | 424B5 | form424b5.htm | 0001493152-24-049831 | 333-276650 | 241546071 | 33 | 691247 | |||
| 2024-12-12 | SC 13D/A | formsc13da.htm | 0001493152-24-049719 | 005-92289 | 241543134 | 34 | 90487 | |||
| 2024-12-11 | 424B5 | form424b5.htm | 0001493152-24-049661 | 333-276650 | 241542453 | 33 | 699924 | |||
| 2024-12-10 | SC 13D/A | formsc13da.htm | 0001493152-24-049352 | 005-92289 | 241537032 | 34 | 88986 | |||
| 2024-12-05 | SC 13D/A | formsc13da.htm | 0001493152-24-048801 | 005-92289 | 241527849 | 34 | 87470 | |||
| 2024-11-25 | 8-K | form8-k.htm | 5.02 | 0001493152-24-047606 | 001-40101 | 241495781 | 34 | 261558 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-118625 | 005-92289 | 241459271 | 34 | 62563 | |||
| 2024-11-01 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-24-043322 | 001-40101 | 241419068 | 34 | 1192977 | 1 | 1 |
| 2024-10-29 | 10-K | form10-k.htm | 0001493152-24-042743 | 001-40101 | 241402194 | 34 | 11725154 | 1 | 1 | |
| 2024-10-02 | 8-K | form8-k.htm | 1.01,8.01,9.01 | 0001493152-24-039218 | 001-40101 | 241347892 | 34 | 1723667 | 1 | 1 |
| 2024-10-02 | 424B5 | form424b5.htm | 0001493152-24-039136 | 333-276650 | 241345614 | 33 | 675548 | |||
| 2024-10-01 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-24-039016 | 001-40101 | 241343174 | 34 | 617520 | 1 | 1 |
| 2024-09-16 | SC 13G | SC 13G | 0001104659-24-100052 | 005-92289 | 241299896 | 34 | 72133 | |||
| 2024-09-12 | 8-K | form8-k.htm | 1.01,3.02,8.01,9.01 | 0001493152-24-036055 | 001-40101 | 241295254 | 34 | 1426788 | 1 | 1 |
| 2024-09-12 | 424B5 | form424b5.htm | 0001493152-24-035877 | 333-276650 | 241293597 | 33 | 803776 | |||
| 2024-09-11 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-24-035737 | 001-40101 | 241291500 | 34 | 371882 | 1 | 1 |
| 2024-08-23 | 8-K | form8-k.htm | 3.01 | 0001493152-24-033753 | 001-40101 | 241237080 | 34 | 257780 | 1 | 1 |
| 2024-07-18 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-24-028343 | 001-40101 | 241125109 | 34 | 373049 | 1 | 1 |
| 2024-07-05 | 8-K | form8-k.htm | 3.01 | 0001493152-24-026349 | 001-40101 | 241102716 | 34 | 257306 | 1 | 1 |
| 2024-06-14 | 10-Q | form10-q.htm | 0001493152-24-023867 | 001-40101 | 241044852 | 34 | 4864290 | 1 | 1 | |
| 2024-06-14 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-24-023860 | 001-40101 | 241044687 | 34 | 999745 | 1 | 1 |
| 2024-05-24 | SC 13D/A | formsc13da.htm | 0001493152-24-021272 | 005-92289 | 24981121 | 34 | 83474 | |||
| 2024-05-20 | 4 | xslF345X05/ownership.xml | 0001493152-24-020660 | 7750 | ||||||
| 2024-05-17 | 8-K | form8-k.htm | 1.01,8.01,9.01 | 0001493152-24-020460 | 001-40101 | 24960754 | 34 | 1334212 | 1 | 1 |
| 2024-05-16 | 424B5 | form424b5.htm | 0001493152-24-020290 | 333-276650 | 24956663 | 33 | 510047 | |||
| 2024-04-02 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-24-012774 | 001-40101 | 24814184 | 34 | 1010117 | 1 | 1 |
| 2024-03-18 | 10-Q | form10-q.htm | 0001493152-24-010354 | 001-40101 | 24760052 | 34 | 4584522 | 1 | 1 | |
| 2024-01-31 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-01-31 17:00:00 | 9999999995-24-000271 | 333-276650 | 24584885 | 33 | 1879 | ||
| 2024-01-31 | 8-K | form8-k.htm | 5.07 | 0001493152-24-004525 | 001-40101 | 24584012 | 34 | 282723 | 1 | 1 |
| 2024-01-29 | CORRESP | filename1.htm | 0001493152-24-004142 | 10570 | ||||||
| 2024-01-29 | UPLOAD | filename1.pdf | 0000000000-24-001087 | 333-276650 | 40460 | |||||
| 2024-01-22 | S-3 | forms-3.htm | 0001493152-24-003291 | 333-276650 | 24549553 | 33 | 485470 | |||
| 2024-01-09 | DEF 14A | formdef14a.htm | 0001493152-24-001830 | 001-40101 | 24523291 | 34 | 2277593 | |||
| 2024-01-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001718996-24-000001 | 005-92289 | 24518884 | 34 | 6773 | |||
| 2023-12-20 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-23-045569 | 001-40101 | 231501379 | 34 | 307257 | 1 | 1 |
| 2023-12-14 | 10-Q | form10-q.htm | 0001493152-23-044892 | 001-40101 | 231487795 | 34 | 3980088 | 1 | 1 | |
| 2023-12-14 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-044891 | 001-40101 | 231487791 | 34 | 943385 | 1 | 1 |
| 2023-11-30 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-043142 | 001-40101 | 231453953 | 34 | 289516 | 1 | 1 |
| 2023-11-03 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-039228 | 001-40101 | 231374601 | 34 | 348373 | 1 | 1 |
| 2023-10-25 | 10-K | form10-k.htm | 0001493152-23-038298 | 001-40101 | 231346919 | 34 | 8475075 | 1 | 1 | |
| 2023-10-25 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-038297 | 001-40101 | 231346909 | 34 | 14455317 | 1 | 1 |
| 2023-09-08 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-032041 | 001-40101 | 231243746 | 34 | 290248 | 1 | 1 |
| 2023-09-07 | 8-K | form8-k.htm | 5.03,9.01 | 0001493152-23-031982 | 001-40101 | 231242649 | 34 | 2342585 | 1 | 1 |
| 2023-08-31 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-23-031061 | 001-40101 | 231229975 | 34 | 289665 | 1 | 1 |
| 2023-08-31 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-23-031359 | 001-40101 | 231229801 | 34 | 289665 | 1 | 1 |
| 2023-08-25 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-23-030245 | 001-40101 | 231209052 | 34 | 291456 | 1 | 1 |
| 2023-08-21 | 8-K | form8-k.htm | 5.07,8.01,9.01 | 0001493152-23-029604 | 001-40101 | 231189159 | 34 | 324205 | 1 | 1 |
| 2023-07-26 | DEF 14A | formdef14a.htm | 0001493152-23-025573 | 001-40101 | 231113493 | 34 | 11054004 | |||
| 2023-06-30 | PRE 14A | formpre14a.htm | 0001493152-23-023136 | 001-40101 | 231062173 | 34 | 5332370 | |||
| 2023-06-27 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-022575 | 001-40101 | 231044441 | 34 | 294619 | 1 | 1 |
| 2023-06-14 | 10-Q | form10-q.htm | 0001493152-23-021287 | 001-40101 | 231015051 | 34 | 5220883 | 1 | 1 | |
| 2023-05-31 | 8-K | form8-k.htm | 1.01,7.01,9.01 | 0001493152-23-019652 | 001-40101 | 23981407 | 34 | 757602 | 1 | 1 |
| 2023-05-22 | 8-K | form8-k.htm | 3.02,9.01 | 0001493152-23-018481 | 001-40101 | 23943171 | 34 | 297041 | 1 | 1 |
| 2023-05-15 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-23-017363 | 001-40101 | 23922552 | 34 | 544069 | 1 | 1 |
| 2023-04-17 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-012566 | 001-40101 | 23824509 | 34 | 7460665 | 1 | 1 |
| 2023-03-30 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-009816 | 001-40101 | 23781588 | 34 | 309514 | 1 | 1 |
| 2023-03-28 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001493152-23-008251,2023-03-28 | 9999999995-23-000686 | 333-234292 | 23771584 | 33 | 1843 | ||
| 2023-03-20 | POS AM | formposam.htm | 0001493152-23-008251 | 333-234292 | 23746690 | 33 | 244443 | |||
| 2023-03-16 | UPLOAD | filename1.pdf | 0000000000-23-002624 | 39795 | ||||||
| 2023-03-16 | 10-Q | form10-q.htm | 0001493152-23-007796 | 001-40101 | 23736484 | 34 | 5065543 | 1 | 1 | |
| 2023-03-13 | CORRESP | filename1.htm | 0001493152-23-007488 | 68211 | ||||||
| 2023-03-08 | UPLOAD | filename1.pdf | 0000000000-23-002277 | 43919 | ||||||
| 2023-02-23 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-005827 | 001-40101 | 23656016 | 34 | 292098 | 1 | 1 |
| 2023-02-15 | 8-K | form8-k.htm | 5.03,5.07,9.01 | 0001493152-23-005199 | 001-40101 | 23635309 | 34 | 308028 | 1 | 1 |
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021743 | 005-92289 | 23630398 | 34 | 69516 | |||
| 2023-02-10 | 8-K | form8-k.htm | 8.01,9.01 | 0001493152-23-004295 | 001-40101 | 23612539 | 34 | 300202 | 1 | 1 |
| 2023-01-24 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-002354 | 001-40101 | 23549010 | 34 | 310095 | 1 | 1 |
| 2023-01-23 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-002198 | 001-40101 | 23544608 | 34 | 290083 | 1 | 1 |
| 2023-01-18 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-001731 | 001-40101 | 23533031 | 34 | 296199 | 1 | 1 |
| 2023-01-17 | DEF 14A | formdef14a.htm | 0001493152-23-001505 | 001-40101 | 23530051 | 34 | 2508183 | |||
| 2023-01-10 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-23-001049 | 001-40101 | 23520165 | 34 | 302894 | 1 | 1 |
| 2023-01-05 | PRE 14A | formpre14a.htm | 0001493152-23-000443 | 001-40101 | 23509836 | 34 | 4844955 | |||
| 2022-12-28 | 4 | xslF345X03/ownership.xml | 0001493152-22-036669 | 4556 | ||||||
| 2022-12-28 | 4 | xslF345X03/ownership.xml | 0001493152-22-036643 | 5860 | ||||||
| 2022-12-20 | 4 | xslF345X03/ownership.xml | 0001493152-22-036060 | 4548 | ||||||
| 2022-12-14 | 10-Q | form10-q.htm | 0001493152-22-035452 | 001-40101 | 221462694 | 34 | 3477686 | 1 | 1 | |
| 2022-12-08 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-22-034831 | 001-40101 | 221451546 | 34 | 9879763 | 1 | 1 |
| 2022-11-30 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-22-034020 | 001-40101 | 221435561 | 34 | 317161 | 1 | 1 |
| 2022-11-10 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-22-031250 | 001-40101 | 221375213 | 34 | 4946805 | 1 | 1 |
| 2022-10-28 | 10-K | form10-k.htm | 0001493152-22-029742 | 001-40101 | 221338443 | 34 | 9205209 | 1 | 1 | |
| 2022-10-28 | 8-K | form8-k.htm | 2.02,7.01,8.01,9.01 | 0001493152-22-029741 | 001-40101 | 221338439 | 34 | 3447868 | 1 | 1 |
| 2022-10-21 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-22-029278 | 001-40101 | 221322279 | 34 | 296173 | 1 | 1 |
| 2022-09-14 | 8-K | form8-k.htm | 7.01,9.01 | 0001493152-22-025861 | 001-40101 | 221243066 | 34 | 285637 | 1 | 1 |
| 2022-08-11 | 3 | xslF345X02/ownership.xml | 0001493152-22-022149 | 7772 | ||||||
| 2022-08-04 | 8-K | form8-k.htm | 1.01,9.01 | 0001493152-22-021361 | 001-40101 | 221137687 | 34 | 548150 | 1 | 1 |
| 2022-08-02 | 3 | xslF345X02/ownership.xml | 0001493152-22-021000 | 5092 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020881 | 4216 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020884 | 5176 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020883 | 4232 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020882 | 5821 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020877 | 6160 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020879 | 6812 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020880 | 5169 | ||||||
| 2022-08-01 | 3 | xslF345X02/ownership.xml | 0001493152-22-020878 | 5798 | ||||||
| 2022-08-01 | SC 13G | SC 13G | 0001104659-22-084430 | 005-92289 | 221122704 | 34 | 80531 | |||
| 2022-07-18 | 6-K | form6-k.htm | 0001493152-22-019531 | 001-40101 | 221088135 | 34 | 325265 | |||
| 2022-07-05 | 6-K | form6-k.htm | 0001493152-22-018457 | 001-40101 | 221063330 | 34 | 53015 | |||
| 2022-06-29 | 6-K | form6-k.htm | 0001493152-22-018099 | 001-40101 | 221054719 | 34 | 49317 | |||
| 2022-06-24 | 6-K | form6-k.htm | 0001493152-22-017706 | 001-40101 | 221040046 | 34 | 51222 | |||
| 2022-06-13 | 6-K | form6-k.htm | 0001493152-22-016599 | 001-40101 | 221012634 | 34 | 5632058 | 1 | 1 | |
| 2022-05-18 | 6-K | form6-k.htm | 0001493152-22-014317 | 001-40101 | 22939079 | 34 | 58537 | |||
| 2022-04-25 | SC 13G | formsc13g.htm | 0001493152-22-010830 | 005-92289 | 22849711 | 34 | 65604 | |||
| 2022-04-13 | 6-K | form6-k.htm | 0001493152-22-009769 | 001-40101 | 22823688 | 34 | 62482 | |||
| 2022-04-12 | 6-K | form6-k.htm | 0001493152-22-009714 | 001-40101 | 22822840 | 34 | 61770 | |||
| 2022-04-07 | 6-K | form6-k.htm | 0001493152-22-009316 | 001-40101 | 22812380 | 34 | 62359 | |||
| 2022-03-21 | 424B3 | form424b3.htm | 0001493152-22-007358 | 333-257104 | 22755774 | 33 | 234121 | |||
| 2022-03-16 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001493152-22-006504,2022-03-16 | 9999999995-22-000649 | 333-257104 | 22746589 | 33 | 1843 | ||
| 2022-03-15 | 6-K | form6-k.htm | 0001493152-22-006886 | 001-40101 | 22741951 | 34 | 6245913 | 1 | 1 | |
| 2022-03-10 | POS AM | formposam.htm | 0001493152-22-006504 | 333-257104 | 22729058 | 33 | 460366 | |||
| 2022-02-28 | 6-K | form6-k.htm | 0001493152-22-005610 | 001-40101 | 22690178 | 34 | 49980 | |||
| 2022-02-23 | 6-K | form6k.htm | 0001493152-22-005232 | 001-40101 | 22663472 | 34 | 42968 | |||
| 2022-02-16 | 6-K | form6-k.htm | 0001493152-22-004803 | 001-40101 | 22644796 | 34 | 40333 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022532 | 005-92289 | 22630411 | 34 | 66421 | |||
| 2022-02-14 | SC 13G/A | AMENDMENT TO SC 13G | 0001387131-22-001737 | 005-92289 | 22624100 | 34 | 84563 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001553350-22-000149 | 005-92289 | 22623159 | 34 | 45294 | |||
| 2022-02-11 | SC 13G/A | sc13g.htm | 0000929638-22-000419 | 005-92289 | 22622415 | 34 | 68837 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0001104659-22-019877 | 005-92289 | 22616802 | 34 | 53248 | |||
| 2022-02-10 | 6-K | form6-k.htm | 0001493152-22-003745 | 001-40101 | 22613885 | 34 | 46411 | |||
| 2022-02-04 | SC 13G/A | sc13ga110022002_02042022.htm | 0000921895-22-000337 | 005-92289 | 22593974 | 34 | 207090 | |||
| 2022-01-20 | SC 13G/A | BRIACELL THERAPEUTICS CORP. | 0000902664-22-000371 | 005-92289 | 22540963 | 34 | 74253 | |||
| 2022-01-20 | 6-K | form6-k.htm | 0001493152-22-001654 | 001-40101 | 22540556 | 34 | 66436 | |||
| 2022-01-05 | 6-K | form6-k.htm | 0001493152-22-000358 | 001-40101 | 22508617 | 34 | 2419608 | |||
| 2022-01-04 | SC 13G/A | SABBY 13G-A BCTX 1.03.22 | 0001535610-22-000014 | 005-92289 | 22503523 | 34 | 13373 | |||
| 2021-12-30 | 6-K | form6-k.htm | 0001493152-21-032819 | 001-40101 | 211532793 | 34 | 56169 | |||
| 2021-12-17 | 6-K | form6-k.htm | 0001493152-21-031750 | 001-40101 | 211498904 | 34 | 47174 | |||
| 2021-12-15 | 6-K | form6-k.htm | 0001493152-21-031513 | 001-40101 | 211493526 | 34 | 961010 | |||
| 2021-12-09 | 6-K | form6-k.htm | 0001493152-21-030957 | 001-40101 | 211481947 | 34 | 70351 | |||
| 2021-11-26 | 424B3 | form-424b3.htm | 0001493152-21-029898 | 333-234292 | 211449057 | 33 | 2938202 | |||
| 2021-11-23 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001493152-21-029260,2021-11-23 | 9999999995-21-004457 | 333-234292 | 211441076 | 33 | 1844 | ||
| 2021-11-19 | POS AM | formposam.htm | 0001493152-21-029260 | 333-234292 | 211425809 | 33 | 11199702 | 1 | 1 | |
| 2021-11-19 | 6-K | form6-k.htm | 0001493152-21-029259 | 001-40101 | 211425767 | 34 | 42686 | |||
| 2021-11-16 | 40-F/A | form40-fa.htm | 0001493152-21-028949 | 001-40101 | 211416075 | 34 | 8310976 | 1 | 1 | |
| 2021-11-12 | 6-K | form6-k.htm | 0001493152-21-028211 | 001-40101 | 211404339 | 34 | 71299 | |||
| 2021-11-05 | 6-K | form6-k.htm | 0001493152-21-027353 | 001-40101 | 211384500 | 34 | 47649 | |||
| 2021-11-02 | 6-K | form6-k.htm | 0001493152-21-026978 | 001-40101 | 211371196 | 34 | 43515 | |||
| 2021-10-29 | 40-F | form40-f.htm | 0001493152-21-026729 | 001-40101 | 211363405 | 34 | 151650 | |||
| 2021-10-29 | 6-K | form6-k.htm | 0001493152-21-026724 | 001-40101 | 211363281 | 34 | 2582539 | |||
| 2021-10-18 | 424B3 | form424b3.htm | 0001493152-21-025689 | 333-257104 | 211328337 | 33 | 28667 | |||
| 2021-10-05 | 6-K | form6-k.htm | 0001493152-21-024627 | 001-40101 | 211306648 | 34 | 42435 | |||
| 2021-09-22 | 6-K | form6-k.htm | 0001493152-21-023360 | 001-40101 | 211269669 | 34 | 38373 | |||
| 2021-09-20 | SC 13D/A | AMENDMENT NO. 1 | 0001214659-21-009658 | 005-92289 | 211264129 | 34 | 53583 | |||
| 2021-09-13 | SC 13G | formsc13g.htm | 0001493152-21-022504 | 005-92289 | 211248706 | 34 | 83132 | |||
| 2021-09-09 | 6-K | form6-k.htm | 0001493152-21-022296 | 001-40101 | 211244441 | 34 | 39234 | |||
| 2021-09-07 | SC 13D | formsc13d.htm | 0001493152-21-022097 | 005-92289 | 211239342 | 34 | 100156 | |||
| 2021-09-01 | 6-K | form6-k.htm | 0001493152-21-021757 | 001-40101 | 211229435 | 34 | 47614 | |||
| 2021-08-23 | 6-K | form6-k.htm | 0001493152-21-020980 | 001-40101 | 211196571 | 34 | 79968 | |||
| 2021-08-19 | 6-K | form6-k.htm | 0001493152-21-020655 | 001-40101 | 211188771 | 34 | 41971 | |||
| 2021-08-17 | SC 13G | SC 13G | 0001104659-21-107003 | 005-92289 | 211182794 | 34 | 62064 | |||
| 2021-08-17 | 6-K | form6-k.htm | 0001493152-21-020421 | 001-40101 | 211182540 | 34 | 18245 | |||
| 2021-08-13 | 6-K | form6-k.htm | 0001493152-21-019567 | 001-40101 | 211168993 | 34 | 147710 | |||
| 2021-08-09 | SC 13D | d87210sc13d.htm | 0001214659-21-008231 | 005-92289 | 211154473 | 34 | 63107 | |||
| 2021-08-04 | SC 13G/A | sc13ga.htm | 0001493152-21-018514 | 005-92289 | 211142617 | 34 | 108265 | |||
| 2021-07-14 | 6-K | form6-k.htm | 0001493152-21-016843 | 001-40101 | 211090285 | 34 | 43437 | |||
| 2021-07-12 | 6-K | form6-k.htm | 0001493152-21-016629 | 001-40101 | 211085596 | 34 | 85657 | |||
| 2021-07-08 | 6-K | form6-k.htm | 0001493152-21-016474 | 001-40101 | 211080863 | 34 | 193157 | |||
| 2021-06-30 | 6-K | form6-k.htm | 0001493152-21-015716 | 001-40101 | 211061973 | 34 | 1173174 | |||
| 2021-06-28 | SC 13G | sc13g.htm | 0001493152-21-015372 | 005-92289 | 211053549 | 34 | 122454 | |||
| 2021-06-25 | 424B3 | form424b3.htm | 0001493152-21-015234 | 333-257104 | 211044906 | 33 | 6344746 | |||
| 2021-06-24 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2021-06-24 17:00:00 | 9999999995-21-002511 | 333-257104 | 211044569 | 33 | 1831 | ||
| 2021-06-22 | CORRESP | filename1.htm | 0001493152-21-014996 | 9578 | ||||||
| 2021-06-21 | UPLOAD | filename1.pdf | 0000000000-21-007591 | 40395 | ||||||
| 2021-06-16 | 6-K | form6-k.htm | 0001493152-21-014535 | 001-40101 | 211021501 | 34 | 85831 | |||
| 2021-06-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001493152-21-014435 | 021-403035 | 211019556 | 33 | 11521 | ||
| 2021-06-15 | F-1 | formf-1.htm | 0001493152-21-014365 | 333-257104 | 211016813 | 33 | 12346298 | 1 | ||
| 2021-06-14 | SC 13G | SC 13G | 0001104659-21-080647 | 005-92289 | 211014035 | 34 | 77837 | |||
| 2021-06-10 | 6-K | form6-k.htm | 0001493152-21-014014 | 001-40101 | 211008026 | 34 | 71599 | |||
| 2021-06-09 | 6-K | form6-k.htm | 0001493152-21-013903 | 001-40101 | 211005182 | 34 | 79018 | |||
| 2021-06-08 | 6-K | form6-k.htm | 0001493152-21-013786 | 001-40101 | 211001335 | 34 | 39900 | |||
| 2021-06-04 | 6-K | form6-k.htm | 0001493152-21-013659 | 001-40101 | 21997504 | 34 | 1018807 | |||
| 2021-06-02 | 6-K | form6-k.htm | 0001493152-21-013395 | 001-40101 | 21987750 | 34 | 120461 | |||
| 2021-05-20 | 6-K | form6-k.htm | 0001493152-21-012289 | 001-40101 | 21941739 | 34 | 108381 | |||
| 2021-05-11 | 6-K | form6-k.htm | 0001493152-21-011017 | 001-40101 | 21911235 | 34 | 55813 | |||
| 2021-04-27 | 6-K | form6-k.htm | 0001493152-21-009850 | 001-40101 | 21859374 | 34 | 447162 | |||
| 2021-04-16 | 6-K | form6-k.htm | 0001493152-21-009020 | 001-40101 | 21831879 | 34 | 53517 | |||
| 2021-04-12 | 6-K | form6-k.htm | 0001493152-21-008530 | 001-40101 | 21820568 | 34 | 64300 | |||
| 2021-04-01 | 6-K | form6-k.htm | 0001493152-21-007640 | 001-40101 | 21796028 | 34 | 951813 | |||
| 2021-03-31 | 6-K | form6-k.htm | 0001493152-21-007438 | 001-40101 | 21793250 | 34 | 56469 | |||
| 2021-03-08 | SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-003307 | 005-92289 | 21722167 | 34 | 86016 | |||
| 2021-03-05 | SC 13G | l1cap_scd13g.htm | 0001079973-21-000150 | 005-92289 | 21718630 | 34 | 46264 | |||
| 2021-03-03 | SC 13G | SABBY 13G BCTX | 0001535610-21-000082 | 005-92289 | 21707241 | 34 | 13349 | |||
| 2021-03-02 | SC 13G | BRIACELL THERAPEUTICS CORP. | 0000902664-21-001692 | 005-92289 | 21702081 | 34 | 81023 | |||
| 2021-03-02 | 6-K | form6-k.htm | 0001493152-21-005141 | 001-40101 | 21700745 | 34 | 96258 | |||
| 2021-02-26 | SC 13G | sc13g.htm | 0000929638-21-000414 | 005-92289 | 21690623 | 34 | 82073 | |||
| 2021-02-26 | SC 13G | sc13g10022bctxf_02262021.htm | 0000921895-21-000562 | 005-92289 | 21684065 | 34 | 228463 | |||
| 2021-02-26 | 424B4 | form424b4.htm | 0001493152-21-004866 | 333-234292 | 21683667 | 33 | 4649026 | |||
| 2021-02-25 | 424B4 | form424b4.htm | 0001493152-21-004840 | 333-234292 | 21681145 | 33 | 4861311 | |||
| 2021-02-23 | EFFECT | xslEFFECTX01/primary_doc.xml | F-1,,2021-02-23 17:00:00 | 9999999995-21-000708 | 333-234292 | 21668340 | 33 | 1830 | ||
| 2021-02-23 | CERT | 8A_Cert_BCTX.pdf | 0001354457-21-000260 | 001-40101 | 21664459 | 34 | 150879 | |||
| 2021-02-23 | 8-A12B | form8a12b.htm | 0001493152-21-004540 | 001-40101 | 21662924 | 34 | 24142 | |||
| 2021-02-18 | CORRESP | filename1.htm | 0001493152-21-004277 | 26163 | ||||||
| 2021-02-18 | CORRESP | filename1.htm | 0001493152-21-004276 | 12044 | ||||||
| 2021-02-18 | CORRESP | filename1.htm | 0001493152-21-004275 | 12031 | ||||||
| 2021-02-18 | F-1/A | formf1a.htm | 0001493152-21-004274 | 333-234292 | 21650124 | 33 | 5112937 | |||
| 2021-02-03 | F-1/A | formf1a.htm | 0001493152-21-002440 | 333-234292 | 21584030 | 33 | 5103064 | |||
| 2021-02-02 | CORRESP | filename1.htm | 0001493152-21-002441 | 22554 | ||||||
| 2021-02-01 | UPLOAD | filename1.pdf | 0000000000-21-001190 | 43236 | ||||||
| 2021-01-15 | F-1/A | formf1a.htm | 0001493152-21-001108 | 333-234292 | 21530393 | 33 | 4881036 | |||
| 2021-01-14 | CORRESP | filename1.htm | 0001493152-21-001110 | 19736 | ||||||
| 2020-12-23 | F-1/A | formf1a.htm | 0001493152-20-024156 | 333-234292 | 201409356 | 33 | 231355 | |||
| 2020-12-22 | CORRESP | filename1.htm | 0001493152-20-024158 | 16370 | ||||||
| 2020-12-21 | UPLOAD | filename1.pdf | 0000000000-20-012286 | 43713 | ||||||
| 2020-12-10 | CORRESP | filename1.htm | 0001493152-20-023258 | 16352 | ||||||
| 2020-12-10 | F-1/A | formf1a.htm | 0001493152-20-023253 | 333-234292 | 201380416 | 33 | 6659427 | |||
| 2020-10-23 | UPLOAD | filename1.pdf | 0000000000-20-010041 | 43696 | ||||||
| 2020-10-20 | CORRESP | filename1.htm | 0001493152-20-019648 | 18490 | ||||||
| 2020-10-20 | F-1/A | formf1a.htm | 0001493152-20-019645 | 333-234292 | 201247417 | 33 | 5305563 | |||
| 2020-10-16 | UPLOAD | filename1.pdf | 0000000000-20-009789 | 45451 | ||||||
| 2020-09-18 | F-1/A | formf1a.htm | 0001493152-20-017990 | 333-234292 | 201182676 | 33 | 6137650 | |||
| 2020-05-27 | CORRESP | filename1.htm | 0001493152-20-009943 | 12011 | ||||||
| 2020-05-27 | F-1/A | formf-1a.htm | 0001493152-20-009927 | 333-234292 | 20916095 | 33 | 6806475 | |||
| 2020-05-18 | F-1/A | formf-1a.htm | 0001493152-20-009237 | 333-234292 | 20887608 | 33 | 6510854 | |||
| 2020-05-15 | CORRESP | filename1.htm | 0001493152-20-009239 | 12013 | ||||||
| 2020-03-13 | CORRESP | filename1.htm | 0001493152-20-003913 | 50102 | ||||||
| 2020-03-13 | F-1/A | formf-1a.htm | 0001493152-20-003911 | 333-234292 | 20713205 | 33 | 6471278 | |||
| 2020-03-09 | UPLOAD | filename1.pdf | 0000000000-20-002083 | 54585 | ||||||
| 2020-02-21 | F-1/A | formf-1a.htm | 0001493152-20-002799 | 333-234292 | 20637557 | 33 | 5335083 | |||
| 2020-01-23 | F-1/A | formf-1a.htm | 0001493152-20-000985 | 333-234292 | 20542321 | 33 | 487676 | |||
| 2020-01-21 | F-1/A | formf-1a.htm | 0001493152-20-000871 | 333-234292 | 20536814 | 33 | 5572134 | |||
| 2019-11-27 | CORRESP | filename1.htm | 0001493152-19-018526 | 16445 | ||||||
| 2019-11-27 | F-1/A | formf-1a.htm | 0001493152-19-018524 | 333-234292 | 191258375 | 33 | 12197281 | |||
| 2019-11-22 | UPLOAD | filename1.pdf | 0000000000-19-015785 | 50146 | ||||||
| 2019-11-12 | CORRESP | filename1.htm | 0001493152-19-016847 | 43908 | ||||||
| 2019-11-12 | F-1/A | formf-1a.htm | 0001493152-19-016844 | 333-234292 | 191206608 | 33 | 5022027 | |||
| 2019-11-08 | UPLOAD | filename1.pdf | 0000000000-19-015343 | 55493 | ||||||
| 2019-11-06 | DEL AM | delam.htm | 0001493152-19-016531 | 333-234292 | 191195757 | 33 | 12921 | |||
| 2019-10-22 | CORRESP | filename1.htm | 0001493152-19-015841 | 127117 | ||||||
| 2019-10-22 | F-1 | formf-1.htm | 0001493152-19-015838 | 333-234292 | 191162310 | 33 | 14256310 | |||
| 2019-10-01 | UPLOAD | filename1.pdf | 0000000000-19-014114 | 84012 | ||||||
| 2019-08-30 | DRS | filename1.htm | 0001493152-19-013547 | 377-02815 | 191069397 | 33 | 13915488 | |||
| 2018-04-10 | D | xslFormDX01/primary_doc.xml | 06b | 0001009448-18-000001 | 021-309749 | 18747471 | 33 | 11716 | ||
| 2014-12-12 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-14-045152 | 021-230050 | 141284470 | 33 | 9028 | ||
| 2014-06-20 | D | xslFormDX01/primary_doc.xml | 06b | 0001140361-14-026175 | 021-219548 | 14931270 | 33 | 9584 |
One latest value per concept from companyfacts (278 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 8.73M | 2026-10-28 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 37.40M | 2026-01-30 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| ifrs-full | AccountingProfit | AccountingProfit | USD | -428,334 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | AccumulatedOtherComprehensiveIncome | AccumulatedOtherComprehensiveIncome | USD | -138,684 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | AdjustedWeightedAverageShares | AdjustedWeightedAverageShares | shares | 4.52M | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInPrepaidExpenses | AdjustmentsForDecreaseIncreaseInPrepaidExpenses | USD | -1.17M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | AdjustmentsForDecreaseIncreaseInTradeAccountReceivable | USD | -1,958 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInDepositsFromBanks | AdjustmentsForIncreaseDecreaseInDepositsFromBanks | CAD | 172,980 | 2019-07-30 | 2019-08-01 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | AdjustmentsForIncreaseDecreaseInTradeAccountPayable | AdjustmentsForIncreaseDecreaseInTradeAccountPayable | USD | -190,504 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AdjustmentsForInterestExpense | AdjustmentsForInterestExpense | USD | 979 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AdjustmentsForSharebasedPayments | AdjustmentsForSharebasedPayments | USD | 3.20M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AdjustmentsForUnrealisedForeignExchangeLossesGains | AdjustmentsForUnrealisedForeignExchangeLossesGains | USD | 884,536 | 2020-08-01 | 2021-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AmortisationExpense | AmortisationExpense | USD | 11,454 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | AmortisationIntangibleAssetsOtherThanGoodwill | AmortisationIntangibleAssetsOtherThanGoodwill | USD | 11,454 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ApplicableTaxRate | ApplicableTaxRate | pure | 0.27 | 2020-08-03 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | Assets | Assets | USD | 46.46M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | BasicEarningsLossPerShare | BasicEarningsLossPerShare | USD/shares | -0.72 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | CashAndCashEquivalents | CashAndCashEquivalents | USD | 44.53M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | CashFlowsFromUsedInFinancingActivities | CashFlowsFromUsedInFinancingActivities | USD | -3.58M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | CashFlowsFromUsedInInvestingActivities | CashFlowsFromUsedInInvestingActivities | CAD | 1.34M | 2019-07-30 | 2019-08-01 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | CashFlowsFromUsedInOperatingActivities | CashFlowsFromUsedInOperatingActivities | USD | -9.16M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ComprehensiveIncome | ComprehensiveIncome | USD | -11.09M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | CurrentAssets | CurrentAssets | USD | 46.23M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | CurrentLiabilities | CurrentLiabilities | USD | 366,291 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | CurrentPrepaidExpenses | CurrentPrepaidExpenses | USD | 1.68M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | CurrentUnsecuredBankLoansReceivedAndCurrentPortionOfNoncurrentUnsecuredBankLoansReceived | CurrentUnsecuredBankLoansReceivedAndCurrentPortionOfNoncurrentUnsecuredBankLoansReceived | CAD | 306,878 | 2020-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 | |
| ifrs-full | DeferredTaxAssets | DeferredTaxAssets | USD | 59,332 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 | |
| ifrs-full | DeferredTaxLiabilities | DeferredTaxLiabilities | USD | 59,332 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 | |
| ifrs-full | DepreciationAndAmortisationExpense | DepreciationAndAmortisationExpense | USD | 11,454 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | DirectorsRemunerationExpense | DirectorsRemunerationExpense | USD | 2.22M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | EffectOfExchangeRateChangesOnCashAndCashEquivalents | EffectOfExchangeRateChangesOnCashAndCashEquivalents | USD | -856,459 | 2020-08-01 | 2021-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | Equity | Equity | USD | 45.82M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | EquityAndLiabilities | EquityAndLiabilities | USD | 46.46M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | ExpenseFromSharebasedPaymentTransactionsWithEmployees | ExpenseFromSharebasedPaymentTransactionsWithEmployees | USD | 3.20M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | GainsLossesOnExchangeDifferencesOnTranslationRecognisedInProfitOrLoss | USD | -5,779 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | GeneralAndAdministrativeExpense | GeneralAndAdministrativeExpense | USD | 5.91M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | GovernmentGrants | GovernmentGrants | USD | 25,986 | 2021-07-31 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | IncreaseDecreaseInCashAndCashEquivalents | IncreaseDecreaseInCashAndCashEquivalents | USD | -12.74M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | IncreaseDecreaseThroughConversionOfConvertibleInstruments | IncreaseDecreaseThroughConversionOfConvertibleInstruments | USD | 43,980 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | IncreaseDecreaseThroughExerciseOfWarrantsEquity | IncreaseDecreaseThroughExerciseOfWarrantsEquity | USD | 6.62M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | IncreaseDecreaseThroughTransfersAndOtherChangesIntangibleAssetsOtherThanGoodwill | IncreaseDecreaseThroughTransfersAndOtherChangesIntangibleAssetsOtherThanGoodwill | USD | 0 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | IntangibleAssetsOtherThanGoodwill | IntangibleAssetsOtherThanGoodwill | USD | 234,156 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | InterestExpense | InterestExpense | USD | 979 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | InterestExpenseOnBorrowings | InterestExpenseOnBorrowings | USD | 5,429 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | InvestmentProperty | InvestmentProperty | USD | 2 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | IssuedCapital | IssuedCapital | USD | 55.85M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | NoncurrentLiabilities | NoncurrentLiabilities | USD | 278,396 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | NumberOfOutstandingShareOptions | NumberOfOutstandingShareOptions | shares | 1.46M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | NumberOfShareOptionsExercisableInSharebasedPaymentArrangement | NumberOfShareOptionsExercisableInSharebasedPaymentArrangement | shares | 1.05M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | NumberOfShareOptionsExpiredInSharebasedPaymentArrangement | NumberOfShareOptionsExpiredInSharebasedPaymentArrangement | shares | 1,667 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement | NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement | shares | 999 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | NumberOfShareOptionsGrantedInSharebasedPaymentArrangement | NumberOfShareOptionsGrantedInSharebasedPaymentArrangement | shares | 787,300 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | NumberOfSharesIssued | NumberOfSharesIssued | shares | 208,300 | 2022-01-31 | 2022 | Q2 | 6-K | 2022-03-15 | 0001493152-22-006886 | |
| ifrs-full | OperatingExpense | OperatingExpense | USD | 11.06M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation | USD | 53,235 | 2020-08-01 | 2021-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | PaymentsForShareIssueCosts | PaymentsForShareIssueCosts | USD | 2.77M | 2020-08-01 | 2021-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities | USD | 16,000 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ProceedsFromBorrowingsClassifiedAsFinancingActivities | ProceedsFromBorrowingsClassifiedAsFinancingActivities | USD | 215,710 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | ProceedsFromExerciseOfWarrants | ProceedsFromExerciseOfWarrants | USD | 6.51M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ProceedsFromIssueOfOrdinaryShares | ProceedsFromIssueOfOrdinaryShares | USD | 26.93M | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | ProceedsFromIssuingShares | ProceedsFromIssuingShares | USD | 24.70M | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | ProfessionalFeesExpense | ProfessionalFeesExpense | USD | 76,627 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ProfitLoss | ProfitLoss | USD | -11.09M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ProfitLossFromOperatingActivities | ProfitLossFromOperatingActivities | USD | -11.06M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | RentalExpense | RentalExpense | USD | 8,600 | 2021-07-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | RepaymentsOfBorrowingsClassifiedAsFinancingActivities | USD | 23,577 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | RepaymentsOfCurrentBorrowings | RepaymentsOfCurrentBorrowings | USD | 274,000 | 2020-08-01 | 2021-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ResearchAndDevelopmentExpense | ResearchAndDevelopmentExpense | USD | 5.15M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | ReserveOfSharebasedPayments | ReserveOfSharebasedPayments | USD | 5.36M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | RetainedEarnings | RetainedEarnings | USD | -27.58M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | RevenueFromGovernmentGrants | RevenueFromGovernmentGrants | USD | 3,388 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | RevenueFromInterest | RevenueFromInterest | USD | 54,373 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | TaxEffectFromChangeInTaxRate | TaxEffectFromChangeInTaxRate | USD | 5,893 | 2018-08-01 | 2019-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | TaxEffectOfForeignTaxRates | TaxEffectOfForeignTaxRates | USD | 30,180 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | TaxExpenseIncomeAtApplicableTaxRate | TaxExpenseIncomeAtApplicableTaxRate | USD | -115,650 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | TradeAndOtherCurrentPayables | TradeAndOtherCurrentPayables | USD | 366,291 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | TradeAndOtherCurrentReceivables | TradeAndOtherCurrentReceivables | USD | 14,532 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | WagesAndSalaries | WagesAndSalaries | USD | 790,349 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | WarrantLiability | WarrantLiability | USD | 278,396 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | WarrantReserve | WarrantReserve | USD | 12.33M | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 | USD/shares | -46.8 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 | USD/shares | 61.83 | 2020-08-01 | 2021-07-31 | 2021 | FY | 40-F/A | 2021-11-16 | 0001493152-21-028949 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019 | USD/shares | 5.74 | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| ifrs-full | WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 | WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 | USD/shares | 6.23 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 | |
| ifrs-full | WeightedAverageShares | WeightedAverageShares | shares | 15.49M | 2021-08-01 | 2022-04-30 | 2022 | Q3 | 6-K | 2022-06-13 | 0001493152-22-016599 |
| us-gaap | AccountsPayableAndOtherAccruedLiabilitiesCurrent | Accounts Payable and Other Accrued Liabilities, Current | USD | 987,109 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 6.99M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 15,233 | 2024-04-30 | 2024 | Q3 | 10-Q | 2024-06-14 | 0001493152-24-023867 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 657,718 | 2023-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -138,684 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 7.92M | 2023-10-31 | 2024 | Q1 | 10-Q | 2023-12-14 | 0001493152-23-044892 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 6.89M | 2023-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 15,271 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature | USD | 20,251 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | -199,207 | 2023-08-01 | 2024-07-31 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.11M | 2022-08-01 | 2022-10-31 | 2023 | Q1 | 10-Q | 2022-12-14 | 0001493152-22-035452 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 1.74M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition | USD | 1.01M | 2025-08-01 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-06-09 | 0001493152-26-027928 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 1.74M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 15,271 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 10.05M | 2021-08-01 | 2022-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | Assets | Assets | USD | 23.58M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 22.04M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 10.69M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | AssetsNoncurrent | Assets, Noncurrent | USD | 1.53M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 9.85M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 9.85M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 13.65M | 2023-10-31 | 2024 | Q1 | 10-Q | 2023-12-14 | 0001493152-23-044892 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -15.01M | 2023-08-01 | 2024-01-31 | 2024 | Q2 | 10-Q | 2024-03-18 | 0001493152-24-010354 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -641,373 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 5.31 | 2023-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 300 | 2023-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 | |
| us-gaap | CommonStockNoParValue | Common Stock, No Par Value | USD/shares | 0 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2024-01-31 | 2024 | Q2 | 10-Q | 2024-03-18 | 0001493152-24-010354 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 8.71M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 8.71M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 120.91M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -17.88M | 2022-08-01 | 2023-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 2.90M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 306,681 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 3.43M | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 35.38M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 14.02M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsInvestmentInSubsidiaries | Deferred Tax Assets, Investment in Subsidiaries | USD | 67,766 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 306,681 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 14.92M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 79.43M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 21.02M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsOtherLossCarryforwards | Deferred Tax Assets, Other Loss Carryforwards | USD | 5.67M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 731 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpense | Deferred Tax Assets, Tax Deferred Expense | USD | 688,831 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 35.08M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts | Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs | USD | 7,750 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 56,755 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | Depreciation | Depreciation | USD | 104,064 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 79,970 | 2024-08-01 | 2025-04-30 | 2025 | Q3 | 10-Q | 2025-06-16 | 0001641172-25-015265 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 11,453 | 2022-08-01 | 2023-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 |
| us-gaap | DerivativeLiabilitiesNoncurrent | Derivative Liability, Noncurrent | USD | 38,939 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -6.97 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -6.97 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.27 | 2024-08-01 | 2025-07-31 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | 0.281 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0.051 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.015 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.002 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.15 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensationNoncash | Employee Benefit and Share-based Payment Arrangement, Noncash | USD | 1.01M | 2025-08-01 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-06-09 | 0001493152-26-027928 |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 2 | 2023-07-31 | 2024 | FY | 10-K | 2024-10-29 | 0001493152-24-042743 | |
| us-gaap | EquitySecuritiesFVNINoncurrent | EquitySecuritiesFVNINoncurrent | USD | 730,028 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | ExtinguishmentOfDebtAmount | Extinguishment of Debt, Amount | USD | 79,717 | 2021-02-27 | 2021-03-01 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | -298,734 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 135,876 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 153,984 | 2023-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 15,271 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 15,271 | 2023-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 15,271 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 15,271 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 15,271 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 305,130 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 169,254 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | FiniteLivedPatentsGross | Finite-Lived Patents, Gross | USD | 305,130 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -17,478 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -166,937 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 6.82M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | GrantsReceivable | Grants Receivable | USD | 1.12M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2021-08-01 | 2022-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2021-08-01 | 2022-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | 29.76M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | 35.33M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign | Income (Loss) from Continuing Operations before Income Taxes, Foreign | USD | 5.57M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeLossFromEquityMethodInvestments | Income (Loss) from Equity Method Investments | USD | -263,477 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2021-07-01 | 2022-06-30 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 9.94M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 1.79M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary | Effective Income Tax Rate Reconciliation, Equity in Earnings (Losses) of Unconsolidated Subsidiary, Amount | USD | -15,420 | 2021-08-01 | 2022-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 1.79M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -5.30M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount | USD | -9.54M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | -7.17M | 2024-08-01 | 2025-07-31 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 531,294 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 81,843 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncomeTaxReconciliationRepatriationOfForeignEarnings | Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Amount | USD | 7,810 | 2021-08-01 | 2022-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 2.23M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 3.71M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 5.30M | 2023-08-01 | 2024-04-30 | 2024 | Q3 | 10-Q | 2024-06-14 | 0001493152-24-023867 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 3,246 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 292,824 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | -961,118 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 211,434 | 2023-08-01 | 2023-10-31 | 2025 | Q1 | 10-Q | 2024-12-16 | 0001493152-24-050214 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 169,254 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | IntangibleAssetsNetIncludingGoodwill | Intangible Assets, Net (Including Goodwill) | USD | 173,072 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-06-09 | 0001493152-26-027928 | |
| us-gaap | InterestAndDebtExpense | Interest and Debt Expense | USD | 53,878 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | InterestExpense | Interest Expense | USD | 979 | 2021-08-01 | 2022-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 29,631 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 633,766 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 23.58M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 7.98M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 38,939 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | LiabilitiesNoncurrent | Liabilities, Noncurrent | USD | 38,939 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | MinorityInterest | Stockholders' Equity Attributable to Noncontrolling Interest | USD | -841,745 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 31.81M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -3.81M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -28.65M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -34.90M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NetIncomeLossAttributableToNoncontrollingInterest | Net Income (Loss) Attributable to Noncontrolling Interest | USD | -421,030 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -34.90M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -5.80M | 2024-08-01 | 2024-10-31 | 2025 | Q1 | 10-Q | 2024-12-16 | 0001493152-24-050214 |
| us-gaap | NoncurrentAssets | Long-Lived Assets | USD | 215,068 | 2023-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 | |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 601,461 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2022-08-01 | 2023-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | Segment | 1 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 36.05M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -36.05M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 26.41M | 2024-07-31 | 2024 | FY | 10-K | 2024-10-29 | 0001493152-24-042743 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 80,967 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 | |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 409,197 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 101,062 | 2025-07-31 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 | |
| us-gaap | PaymentsForRepurchaseOfEquity | Payments for Repurchase of Equity | USD | 47,294 | 2022-08-01 | 2023-07-31 | 2024 | FY | 10-K | 2024-10-29 | 0001493152-24-042743 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 2.89M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 377,000 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | PaymentsToAcquireOtherInvestments | Payments to Acquire Other Investments | USD | 300,000 | 2022-08-01 | 2023-07-31 | 2024 | FY | 10-K | 2024-10-29 | 0001493152-24-042743 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 127,049 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | PaymentsToAcquireShortTermInvestments | Payments to Acquire Short-term Investments | USD | 24.59M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | PreferredStockDividendsAndOtherAdjustments | Preferred Stock Dividends and Other Adjustments | USD | -14.28M | 2023-08-01 | 2023-10-31 | 2024 | Q1 | 10-Q | 2023-12-14 | 0001493152-23-044892 |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 813,987 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | PrepaidExpenseNoncurrent | Prepaid Expense, Noncurrent | USD | 315,703 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | ProceedsFromGrantors | Proceeds from Grantors | USD | 936,363 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 26.93M | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 31.81M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 24.70M | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ProceedsFromIssuanceOfUnsecuredDebt | Proceeds from Issuance of Unsecured Debt | USD | 215,710 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 50.90M | 2025-08-01 | 2025-10-31 | 2026 | Q1 | 10-Q | 2025-12-11 | 0001493152-25-027240 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 34.71M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ProceedsFromRepaymentsOfRelatedPartyDebt | Proceeds from (Repayments of) Related Party Debt | USD | 175,000 | 2023-12-20 | 2024 | FY | 10-K | 2024-10-29 | 0001493152-24-042743 | |
| us-gaap | ProceedsFromRepurchaseOfEquity | Proceeds from (Repurchase of) Equity | USD | 1.61M | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ProceedsFromSaleOfShortTermInvestments | Proceeds from Sale of Short-term Investments | USD | 21.29M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 821,015 | 2024-08-01 | 2025-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 1.21M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -35.33M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | PropertyPlantAndEquipmentAdditions | Property, Plant and Equipment, Additions | USD | 127,049 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 456,801 | 2024-07-31 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 319,804 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | RepaymentsOfShortTermDebt | Repayments of Short-term Debt | USD | 239,000 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | RepaymentsOfUnsecuredDebt | Repayments of Unsecured Debt | USD | 307,108 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 29.24M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -146.66M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | SalariesAndWages | Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold | USD | 1.75M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 1.13M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price | USD/shares | 6.19 | 2021-06-03 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-08-01 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-06-09 | 0001493152-26-027928 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1 | 2021-04-11 | 2021-04-12 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.041 | 2024-08-01 | 2025-07-31 | 2026 | Q3 | 10-Q | 2026-06-09 | 0001493152-26-027928 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecreaseWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Period Increase (Decrease), Weighted Average Exercise Price | USD/shares | 5.68 | 2021-08-01 | 2022-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 796.88 | 2021-04-11 | 2021-04-12 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable | shares | 63,690 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions | Share-based Payment Arrangement, Option, Exercise Price Range, Shares Outstanding | shares | 335,332 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | SharePrice | Share Price | USD/shares | 4.18 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-06-09 | 0001493152-26-027928 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 10.69M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -3.78M | 2023-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 15.56M | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 329,670 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 0 | 2025-08-01 | 2025-10-31 | 2026 | Q1 | 10-Q | 2025-12-11 | 0001493152-25-027240 |
| us-gaap | StockIssuedDuringPeriodSharesShareBasedCompensationForfeited | Shares Issued, Shares, Share-based Payment Arrangement, Forfeited | shares | 667,366 | 2022-02-01 | 2022-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 301,600 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 329,670 | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 31.81M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 13.61M | 2020-08-01 | 2021-07-31 | 2022 | FY | 10-K | 2022-10-28 | 0001493152-22-029742 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensationGross | Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture | USD | 5.59M | 2022-02-01 | 2022-04-30 | 2023 | Q3 | 10-Q | 2023-06-14 | 0001493152-23-021287 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 377,000 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 9.10M | 2021-08-01 | 2022-07-31 | 2023 | FY | 10-K | 2023-10-25 | 0001493152-23-038298 |
| us-gaap | TaxesExcludingIncomeAndExciseTaxes | Taxes, Miscellaneous | USD | 965,764 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | UnrealizedGainLossOnInvestments | Unrealized Gain (Loss) on Investments | USD | 14,804 | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2024-07-31 | 2025 | FY | 10-K | 2025-10-16 | 0001493152-25-018212 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 1.79M | 2023-08-01 | 2024-07-31 | 2024 | FY | 10-K | 2024-10-29 | 0001493152-24-042743 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 5.01M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 5.01M | 2025-08-01 | 2026-07-31 | 2026 | FY | 10-K | 2026-10-28 | 0001493152-26-049041 |